$NXDR 4/A SEC Filings

Filed On	Filing
20 Mar 2026	Form 4/A: Tolia Nirav N, Director Granted 1,768,346 Performance Stock Units (PSU) · Granted 1,768,346 Restricted Stock Units (RSU)
20 Mar 2026	Form 4/A: Kiernan Michael, Chief Revenue Officer Granted 442,086 Performance Stock Units (PSU) · Granted 442,086 Restricted Stock Units (RSU)
20 Mar 2026	Form 4/A: Ponnambalam Indrajit, CFO and Treasurer Granted 1,554,806 Performance Stock Units (PSU)
20 Mar 2026	Form 4/A: Schwartz Sophia, General Counsel and Secretary Granted 471,559 Performance Stock Units (PSU) · Granted 471,559 Restricted Stock Units (RSU)
20 Mar 2026	Form 4/A: Lisowski Craig, President of Products Granted 663,129 Performance Stock Units (PSU) · Granted 663,129 Restricted Stock Units (RSU)
07 Apr 2022	Form 4/A: Kilgore Leslie J, Director Granted 720,335 Class B Common Stock
10 Jan 2022	Form 4/A: Wishom Andrea M, Director Granted 229,820 Stock Option (Right to Buy)
10 Jan 2022	Form 4/A: Orta John, Head of Legal and Secretary Granted 459,321 Class B Common Stock · Granted 712,352 Stock Option (Right to Buy)
10 Jan 2022	Form 4/A: Kilgore Leslie J, Director Granted 720,332 Class B Common Stock
07 Jan 2022	Form 4/A: Friar Sarah, Director Received 500,000 shares as a grant or award ($5M) · Granted 13,430,701 Class B Common Stock · Granted 5,355,958 Stock Option (Right to Buy)
07 Jan 2022	Form 4/A: Doyle Michael, CFO and Treasurer Granted 2,430,465 Stock Option (Right to Buy)
07 Jan 2022	Form 4/A: Bryant John Hope, Director Granted 229,820 Stock Option (Right to Buy)
07 Jan 2022	Form 4/A: Andersen Heidi, Head of Revenue Granted 1,478,306 Stock Option (Right to Buy)

Comments